Cisplatin and Hyperthermia Treatment of A C3H Mammary Carcinoma in Vivo: Importance of sequence, interval, drug dose, and temperature

References

• Dahl O. Hyperthermia and drugs. Hyperthermia, D J Watmough, W M Ross. Blackie, Glasgow 1986; 121–53
   Google Scholar
• Hahn G M. Hyperthermia and cancer53. Plenum Press, New York, London 1982
   Google Scholar
• Herman T S, Teicher B A, Jochelson M, Clark J, Svensson G, Coleman C N. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 1988; 4: 143–58
   PubMed Web of Science ®Google Scholar
• Engelhardt R. Whole body hyperthermia. Hyperthermic oncology 1988, T Sugahara, M Saito. Taylor and Francis, London, New York, Philadelphia 1989; Vol. 2: 69–74
   Google Scholar
• Herman T S, Jochelson M S, Teicher B A, et al. A phase I-II trial of cisplatin hyperthermia and radition in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys 1989; 17: 1273–9
   PubMed Web of Science ®Google Scholar
• Green D M. A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy. Int J Hyperthermia 1989; 5: 13–21
   PubMed Web of Science ®Google Scholar
• Calabresi F, Carlini P, Arena M G, . Superficial hyperthermia combined with cisplatinum chemotherapy: preliminary results. Hyperthermic oncology 1988, T Sugahara, M Saito, et al. Taylor and Francis, London, New York, Philadelphia 1989; Vol. 1: 516–7
   Google Scholar
• Urano M, Kahn J, Kenton L A. The effect of cis-di-amminedichloroplatinum (II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Int J Hyperthermia 1990; 6: 563–70
   PubMed Web of Science ®Google Scholar
• Lindegaard J C, Overgaard J. Factors of importance for the development of the step-down heating effect in a C3H mammary carcinoma in vivo. Int J Hyperthermia 1987; 3: 79–91
   PubMed Web of Science ®Google Scholar
• von der Maase H, Overgaard J. Interactions of radiation and cancer chemotherapeutic drugs in a C3H mouse mammary carcinoma. Acta Radiol Oncol 1985; 24: 181–187
   PubMed Web of Science ®Google Scholar
• Grau C, Overgaard J. Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mammary carcinoma in vivo. Int J Radiat Oncol Biol Phys 1990; 18: 265–9
   Google Scholar
• Steel G G, Peckham M J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979; 5: 85–91
   PubMed Web of Science ®Google Scholar
• Begg A C, Denekamp J. Stromal damage as a complication in the interpretation of tumor growth delay. Eur J Cancer Clin Oncol 1983; 19: 1639–43
   PubMedGoogle Scholar
• Monge O R, Rofstad E K, Kaalhus O. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: single fraction heat and drug treatment. Eur J Cancer Clin Oncol 1988; 24: 1661–9
   PubMedGoogle Scholar
• Begg A C. Analysis of growth delay data: potential pitfalls. Br J Cancer 1980; 41: 93–7
   Web of Science ®Google Scholar
• Fisher G A, Hahn G M. Enhancement of cis-platinum (II) diamine-dichloride cytoxicity by hyperthermia. Natl Cancer Inst Monogr 1982; 61: 255–7
   Google Scholar
• Miller R C, Roizin-Towle L, Komatsu K, Richards M, Hall E J. Interaction of heat with X-rays and cis-platinum; cell lethality and oncogenic transformation. Int J Hyperthermia 1989; 5: 697–705
   PubMed Web of Science ®Google Scholar
• Alberts D S, Peng Y-M, George Chen H-S, Moon T E, Cetas T C, Hoeschele J D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. JNCI 1980; 65: 455–61
   PubMed Web of Science ®Google Scholar
• Dahl O, Mella O. Timing and sequencing of hyperthermia and drugs. Hyperthermic oncology 1984, J Overgaard. Taylor and Francis, London, Philadelphia 1984; Vol. 1: 425–8
   Google Scholar
• Douple E B, Jones E L, Kellogg K C, Van Buren T. Treatment sequence effects of combined cisplatin and hyperthermia in a murine tumor system. Hyperthermic Oncology 1988, T Sugahara, M Saito. Taylor and Francis, London, New York, Philadelphia 1989; Vol. 1: 221–2
   Google Scholar
• Douple E B, Totten M D, Spencer F. Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin. Natl Cancer Inst Monogr 1988; 129–32
   Google Scholar
• Riviere E J, Page R L, Dewhirst M W, Tyczkowska K, Thrall D E. Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. Int J Hyperthermia 1986; 2: 351–8
   PubMedGoogle Scholar
• Song C W. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984; 44: 4721s–30s
   PubMed Web of Science ®Google Scholar
• Overgaard J, Radacic M, Grau C. Interaction of hyperthermia and cis-diaminechloroplatinum (II) alone or combined with radiotherapy in a C3H mammary carcinoma in vivo. Cancer Res 1991; 51: 707–11
   PubMed Web of Science ®Google Scholar
• Mella O. Combined hyperthermia and cis-diamminedichloro-platinum in BD IX rats with transplanted BT4A tumours. Int J Hyperthermia 1985; 1: 171–83
   PubMedGoogle Scholar
• Lindegaard J C, Nielsen O S. Thermotolerance in the mouse foot estimated at various levels of normal tissue damage. Int J Radiat Oncol Biol Phys 1989; 16: 1543–9
   PubMed Web of Science ®Google Scholar